ARCHIVES

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

This article is from The Cancer Letter archive.

Vol. 40 No. 25 | June 20, 2014

Download PDF Visit The Full Archive

Related Articles

Four New Centers To Compete In ’84, DeVita Tells Pane

December 16, 1983

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

February 29, 2008

Science Policcy: HHS Concludes NIH May und Human Stem Cell REsearch

January 22, 1999

Competition For Center Grants Higher In FY95, Kimes Tells BSC

November 25, 1994

Funding opportunties listed.

December 3, 2004

Mouse Strains For Retrovirus Research Available From NCU

March 23, 1984